维普期刊资源整合服务平台（V6.5）

229篇 您的检索式：作者名="Vogel CL"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Dual HER2-targeted approaches in HER2- positive breast cancer 显示文摘	Ahn ER Vogel CL	2012	Breast Cancer Res Treat2012，131，2：	1
2	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-over- expressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
3	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	JClin Oncol1999，17，9：	1
4	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D		0，，03：	1
5	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
6	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
7	Efficacy and safety of Herceptin (trastuzumab humanized anti-HER2 antibody) as a single agent in first line treatment of HER2 overexpressing metastatic breast cancer(HER2+/MBC)显示文摘	Vogel CL Cobleigh MA Trpathy D	1998	Breast Cancer Res Treat1998，50，：	1
8	A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States显示文摘	Vogel CL Bayley AC Brooker RJ		0，，05：	1
9	Gemcitabine as First-line Therapy in patients with metastatic breast cancer:a phase Ⅱ trail显示文摘	Blackstein M Vogel CL Amblinder R	2002	Oncology2002，62，1：	1
10	Dual HER2-targeted approaches in HER2-positive breast cancer显示文摘	Ahn ER Vogel CL	2012	Breast Cancer Res Treat2012，131，2：	1
11	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overex- pressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease 显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
12	Efficacy and safety of Herceptin (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherpy for metastatic breast cancer显示文摘	Cobleigh MA Vogel CL Tripathy D		Pro Am Soc Clin Oncol0，1，：	1
13	Multicenter phase Ⅱ trial of weekly paclitaxel in women with metastatic breast cancer显示文摘	Perej EA Vogel CL Irwin DH	2001	J Clin Ocolo2001，19，22：	1
14	Monotherapy of metastatic breast cancer:a review of newer agents显示文摘	Vogel CL Nabholtz JM	1999	Oncologist1999，4，1：	1
15	Efficacy and safety of tras- tuzumab as a single agent in first-line treatment of HER2-overexpress- ing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	Journal of Clinical Oncology2002，20，3：	1
16	Toremifene for breast cancer: a review of 20 years of data 显示文摘	Vogel CL Johnston MA Capers C	2014	Clin Breast Cancer2014，14，1：	1
17	Activity and Safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer:A stratified phaseⅡstudy显示文摘	Hochster HS Vogel CL Burman SL	2001	Oncologist2001，6，3：	1
18	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
19	A review of vinorelbine in the treatment of breast cancer 显示文摘	Domenech GH Vogel CL	2001	Clin Breast Cancer2001，2，2：	1
20	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metasta-tic disease 显示文摘	Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示